125 related articles for article (PubMed ID: 25542424)
1. The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer.
Deng H; Lv L; Li Y; Zhang C; Meng F; Pu Y; Xiao J; Qian L; Zhao W; Liu Q; Zhang D; Wang Y; Zhang H; He Y; Zhu J
Biochim Biophys Acta; 2015 Mar; 1852(3):520-8. PubMed ID: 25542424
[TBL] [Abstract][Full Text] [Related]
2. miR-193a-3p regulation of chemoradiation resistance in oesophageal cancer cells via the PSEN1 gene.
Meng F; Qian L; Lv L; Ding B; Zhou G; Cheng X; Niu S; Liang Y
Gene; 2016 Apr; 579(2):139-45. PubMed ID: 26743123
[TBL] [Abstract][Full Text] [Related]
3. MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene.
Lv L; Li Y; Deng H; Zhang C; Pu Y; Qian L; Xiao J; Zhao W; Liu Q; Zhang D; Wang Y; Zhang H; He Y; Zhu J
Cancer Lett; 2015 Feb; 357(1):105-113. PubMed ID: 25444900
[TBL] [Abstract][Full Text] [Related]
4. The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer.
Li Y; Deng H; Lv L; Zhang C; Qian L; Xiao J; Zhao W; Liu Q; Zhang D; Wang Y; Yan J; Zhang H; He Y; Zhu J
Oncotarget; 2015 Apr; 6(12):10195-206. PubMed ID: 25991669
[TBL] [Abstract][Full Text] [Related]
5. The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expression.
Lv L; Deng H; Li Y; Zhang C; Liu X; Liu Q; Zhang D; Wang L; Pu Y; Zhang H; He Y; Wang Y; Yu Y; Yu T; Zhu J
Cell Death Dis; 2014 Sep; 5(9):e1402. PubMed ID: 25188512
[TBL] [Abstract][Full Text] [Related]
6. miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the oxidative stress pathway.
Deng H; Lv L; Li Y; Zhang C; Meng F; Pu Y; Xiao J; Qian L; Zhao W; Liu Q; Zhang D; Wang Y; Zhang H; He Y; Zhu J
Mol Cancer; 2014 Oct; 13():234. PubMed ID: 25311867
[TBL] [Abstract][Full Text] [Related]
7. The LncRNA H19/miR-193a-3p axis modifies the radio-resistance and chemotherapeutic tolerance of hepatocellular carcinoma cells by targeting PSEN1.
Ma H; Yuan L; Li W; Xu K; Yang L
J Cell Biochem; 2018 Nov; 119(10):8325-8335. PubMed ID: 29968942
[TBL] [Abstract][Full Text] [Related]
8. MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene.
Pu Y; Zhao F; Wang H; Cai S
Sci Rep; 2017 Mar; 7():44218. PubMed ID: 28281638
[TBL] [Abstract][Full Text] [Related]
9. MiR-193a regulates chemoresistance of human osteosarcoma cells via repression of IRS2.
Wang H; Zhao F; Cai S; Pu Y
J Bone Oncol; 2019 Aug; 17():100241. PubMed ID: 31193934
[TBL] [Abstract][Full Text] [Related]
10. MiR-34b-3p Represses the Multidrug-Chemoresistance of Bladder Cancer Cells by Regulating the CCND2 and P2RY1 Genes.
Tan Y; Zhang T; Zhou L; Liu S; Liang C
Med Sci Monit; 2019 Feb; 25():1323-1335. PubMed ID: 30778022
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of SRSF2 expression.
Ma K; He Y; Zhang H; Fei Q; Niu D; Wang D; Ding X; Xu H; Chen X; Zhu J
J Biol Chem; 2012 Feb; 287(8):5639-49. PubMed ID: 22117060
[TBL] [Abstract][Full Text] [Related]
12. BMI1 activates P-glycoprotein via transcription repression of
Chen MK; Zhou JH; Wang P; Ye YL; Liu Y; Zhou JW; Chen ZJ; Yang JK; Liao DY; Liang ZJ; Xie X; Zhou QZ; Xue KY; Guo WB; Xia M; Bao JM; Yang C; Duan HF; Wang HY; Huang ZP; Qin ZK; Liu CD
Aging (Albany NY); 2021 Jul; 13(14):18310-18330. PubMed ID: 34270461
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.
Zhang J; Wang S; Han F; Li J; Yu L; Zhou P; Chen Z; Xue S; Dai C; Li Q
Gene; 2016 Apr; 579(2):146-52. PubMed ID: 26723509
[TBL] [Abstract][Full Text] [Related]
14. microRNA expression profiles as decision-making biomarkers in the management of bladder cancer.
Amir S; Mabjeesh NJ
Histol Histopathol; 2017 Feb; 32(2):107-119. PubMed ID: 27586262
[TBL] [Abstract][Full Text] [Related]
15. LncRNA-MALAT1 mediates cisplatin resistance via miR-101-3p/VEGF-C pathway in bladder cancer.
Liu P; Li X; Cui Y; Chen J; Li C; Li Q; Li H; Zhang X; Zu X
Acta Biochim Biophys Sin (Shanghai); 2019 Nov; 51(11):1148-1157. PubMed ID: 31650173
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CircRNA BCRC4 regulates cell apoptosis and MicroRNA-101/EZH2 signaling in bladder cancer.
Li B; Xie F; Zheng FX; Jiang GS; Zeng FQ; Xiao XY
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):886-890. PubMed ID: 29270748
[TBL] [Abstract][Full Text] [Related]
17. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-223-3p inhibits human bladder cancer cell migration and invasion.
Guo J; Cao R; Yu X; Xiao Z; Chen Z
Tumour Biol; 2017 Feb; 39(2):1010428317691678. PubMed ID: 28222670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
